blinding of bioequivalence trials (9of11) gcp data integrity
Published 4 years ago • 2.3K plays • Length 18:22Download video MP4
Download video MP3
Similar videos
-
25:57
data integrity issues in bioequivalence studies
-
17:43
bioavailability/bioequivalence site evaluation during the pandemic
-
45:10
unblinding – let me count the ways… (8of11) gcp data integrity
-
56:11
quality and control of clinical trial data (6of11) gcp data integrity workshop
-
33:43
data quality: why do we care? (1of11) gcp data integrity
-
19:15
bioequivalence regulations and product-specific guidances
-
1:56:59
bioequivalence studies with pharmacokinetic endpoints for drugs submitted under an anda
-
2:01:02
fda draft guidance on statistical approaches to establishing bioequivalence
-
17:53
common deficiencies for study sample reanalysis in pk be for andas - bioanalysis 2020
-
4:57
thawing and reconstitution of cryosuspension hepatocytes video
-
1:23
bioequivalence clinical trials - prorelix research
-
19:20
review of clinical endpoint bioequivalence studies in andas (17/28) generic drugs forum 2017
-
6:59
emulating clinical trials for precision medicine with... - jonas béal - transmed - ismb 2020 posters
-
33:03
bioanalytical inspections: overview and case studies – june 17, 2019
-
46:23
fda study data technical conformance guide version 4.2 – nov. 27, 2018
-
19:32
bioequivalence site and manufacturing facility information in applications (17of27) gdf 2018
-
8:19
building an immunoglobulin fold
-
28:55
steady state pharmacokinetics and bioequivalence studies
-
0:37
see it all: western blotting images with precisionab™ antibodies